Imprimis Pharmaceuticals to make compounded and customisable formulation of pyrimethamine and leucovorin available for physicians to prescribe for their patients as an alternative to Daraprim
22 October 2015 - Imprimis Pharmaceuticals is now offering customisable compounded formulations of pyrimethamine and leucovorin in oral capsules starting as low as $99.00 for a 100 count bottle, or at a cost of under a dollar per capsule.